Skip to main content
icon for Casos de sarampo nos EUA até 31 de julho?

Casos de sarampo nos EUA até 31 de julho?

icon for Casos de sarampo nos EUA até 31 de julho?

Casos de sarampo nos EUA até 31 de julho?

$38,403 Vol.

31 jul 2026
Polymarket

$38,403 Vol.

Polymarket

2300

$10,634 Vol.

89%

2350

$3,660 Vol.

14%

2400

$14,737 Vol.

2%

This market will resolve to "Yes" if there have been the specified amount or more confirmed cases of Measles (Rubeola) in humans in the territory of the United States of America in 2026, according to the CDC case counter by July 31, 2026, 11:59 PM ET. Otherwise, this market will resolve to "No". The resolution source for this market will be the CDC Measles (Rubeola) counter 'Total Cases' in 2026 (see: https://www.cdc.gov/measles/data-research/index.html) at the resolution time. If the counter becomes unavailable, another credible source will be used. Note: Only cases reported by the CDC Measles (Rubeola) counter will qualify, regardless of reports from U.S. State agencies or other sources.**Sustained measles transmission in under-vaccinated U.S. communities continues to drive case counts higher.** As of June 25, 2026, the CDC has confirmed 2,134 measles cases for the year across 38 jurisdictions and 30 outbreaks, with 93% of cases unvaccinated or of unknown status and most linked to ongoing chains from 2025. Recent weekly additions of 30–43 cases reflect persistent local spread, particularly in areas with MMR coverage below herd-immunity thresholds. CDC officials have highlighted elevated importation risk from international travel during summer months, which could accelerate incidence through July. Official surveillance updates, typically released mid-week, and any new state-reported clusters will provide the clearest near-term signals for traders assessing totals by July 31.

This market will resolve to "Yes" if there have been the specified amount or more confirmed cases of Measles (Rubeola) in humans in the territory of the United States of America in 2026, according to the CDC case counter by July 31, 2026, 11:59 PM ET. Otherwise, this market will resolve to "No".

The resolution source for this market will be the CDC Measles (Rubeola) counter 'Total Cases' in 2026 (see: https://www.cdc.gov/measles/data-research/index.html) at the resolution time. If the counter becomes unavailable, another credible source will be used.

Note: Only cases reported by the CDC Measles (Rubeola) counter will qualify, regardless of reports from U.S. State agencies or other sources.
Volume
$38,403
Data de Término
31 jul 2026
Mercado Aberto
Jul 1, 2026, 1:41 AM ET
This market will resolve to "Yes" if there have been the specified amount or more confirmed cases of Measles (Rubeola) in humans in the territory of the United States of America in 2026, according to the CDC case counter by July 31, 2026, 11:59 PM ET. Otherwise, this market will resolve to "No". The resolution source for this market will be the CDC Measles (Rubeola) counter 'Total Cases' in 2026 (see: https://www.cdc.gov/measles/data-research/index.html) at the resolution time. If the counter becomes unavailable, another credible source will be used. Note: Only cases reported by the CDC Measles (Rubeola) counter will qualify, regardless of reports from U.S. State agencies or other sources.
This market will resolve to "Yes" if there have been the specified amount or more confirmed cases of Measles (Rubeola) in humans in the territory of the United States of America in 2026, according to the CDC case counter by July 31, 2026, 11:59 PM ET. Otherwise, this market will resolve to "No". The resolution source for this market will be the CDC Measles (Rubeola) counter 'Total Cases' in 2026 (see: https://www.cdc.gov/measles/data-research/index.html) at the resolution time. If the counter becomes unavailable, another credible source will be used. Note: Only cases reported by the CDC Measles (Rubeola) counter will qualify, regardless of reports from U.S. State agencies or other sources.**Sustained measles transmission in under-vaccinated U.S. communities continues to drive case counts higher.** As of June 25, 2026, the CDC has confirmed 2,134 measles cases for the year across 38 jurisdictions and 30 outbreaks, with 93% of cases unvaccinated or of unknown status and most linked to ongoing chains from 2025. Recent weekly additions of 30–43 cases reflect persistent local spread, particularly in areas with MMR coverage below herd-immunity thresholds. CDC officials have highlighted elevated importation risk from international travel during summer months, which could accelerate incidence through July. Official surveillance updates, typically released mid-week, and any new state-reported clusters will provide the clearest near-term signals for traders assessing totals by July 31.

This market will resolve to "Yes" if there have been the specified amount or more confirmed cases of Measles (Rubeola) in humans in the territory of the United States of America in 2026, according to the CDC case counter by July 31, 2026, 11:59 PM ET. Otherwise, this market will resolve to "No".

The resolution source for this market will be the CDC Measles (Rubeola) counter 'Total Cases' in 2026 (see: https://www.cdc.gov/measles/data-research/index.html) at the resolution time. If the counter becomes unavailable, another credible source will be used.

Note: Only cases reported by the CDC Measles (Rubeola) counter will qualify, regardless of reports from U.S. State agencies or other sources.
Volume
$38,403
Data de Término
31 jul 2026
Mercado Aberto
Jul 1, 2026, 1:41 AM ET
This market will resolve to "Yes" if there have been the specified amount or more confirmed cases of Measles (Rubeola) in humans in the territory of the United States of America in 2026, according to the CDC case counter by July 31, 2026, 11:59 PM ET. Otherwise, this market will resolve to "No". The resolution source for this market will be the CDC Measles (Rubeola) counter 'Total Cases' in 2026 (see: https://www.cdc.gov/measles/data-research/index.html) at the resolution time. If the counter becomes unavailable, another credible source will be used. Note: Only cases reported by the CDC Measles (Rubeola) counter will qualify, regardless of reports from U.S. State agencies or other sources.

Cuidado com os links externos.

Frequently Asked Questions

"Casos de sarampo nos EUA até 31 de julho?" is a prediction market on Polymarket with 4 possible outcomes where traders buy and sell shares based on what they believe will happen. The current leading outcome is "2200" at 100%, followed by "2300" at 89%. Prices reflect real-time crowd-sourced probabilities. For example, a share priced at 100¢ implies that the market collectively assigns a 100% chance to that outcome. These odds shift continuously as traders react to new developments and information. Shares in the correct outcome are redeemable for $1 each upon market resolution.

As of today, "Casos de sarampo nos EUA até 31 de julho?" has generated $38.4K in total trading volume since the market launched on Jul 1, 2026. This level of trading activity reflects strong engagement from the Polymarket community and helps ensure that the current odds are informed by a deep pool of market participants. You can track live price movements and trade on any outcome directly on this page.

To trade on "Casos de sarampo nos EUA até 31 de julho?," browse the 4 available outcomes listed on this page. Each outcome displays a current price representing the market's implied probability. To take a position, select the outcome you believe is most likely, choose "Yes" to trade in favor of it or "No" to trade against it, enter your amount, and click "Trade." If your chosen outcome is correct when the market resolves, your "Yes" shares pay out $1 each. If it's incorrect, they pay out $0. You can also sell your shares at any time before resolution if you want to lock in a profit or cut a loss.

The current frontrunner for "Casos de sarampo nos EUA até 31 de julho?" is "2200" at 100%, meaning the market assigns a 100% chance to that outcome. The next closest outcome is "2300" at 89%. These odds update in real-time as traders buy and sell shares, so they reflect the latest collective view of what's most likely to happen. Check back frequently or bookmark this page to follow how the odds shift as new information emerges.

The resolution rules for "Casos de sarampo nos EUA até 31 de julho?" define exactly what needs to happen for each outcome to be declared a winner — including the official data sources used to determine the result. You can review the complete resolution criteria in the "Rules" section on this page above the comments. We recommend reading the rules carefully before trading, as they specify the precise conditions, edge cases, and sources that govern how this market is settled.